By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


pSivida Limited 

Level 12, BGC Centre
28 The Esplanade
Perth  Western Australia  6000  Australia
Phone: 61-8-9226-5099 Fax: 61-8-9226-5499



Company News
pSivida Corp (PSDV) Gains Big on Buyout Rumor 6/19/2013 8:10:00 AM
pSivida Limited (PSD.AX) Receives $15 Million Payment from Alimera Sciences (ALIM) 4/29/2010 7:12:29 AM
pSivida Corporation Names Paul Ashton, Ph.D. President and Chief Executive Officer 2/2/2009 7:24:51 AM
pSivida Limited (PSD.AX) New Evaluation for Cardiovascular Drug Delivery 12/16/2008 6:34:45 AM
pSivida Limited (PSD.AX) New Clinical Trial for Drug Delivery Device in AMD 12/11/2008 6:34:18 AM
pSivida Limited (PSD.AX) Reports Results for the First Quarter Ended September 30, 2008 11/11/2008 1:52:03 PM
pSivida Limited (PSD.AX) Release: Results From The Six-Month Interim Readout Of The Human PK Iluvien(TM) Study 10/1/2008 11:05:39 AM
pSivida Limited (PSD.AX) Announcement: DSMB Supports Continuation of the Phase III Clinical Trial of Iluvien(TM) for the Treatment of DME 9/25/2008 8:47:41 AM
pSivida Limited (PSD.AX) Quarterly Highlights 7/31/2008 11:17:29 AM
pSivida Limited (PSD.AX) Announces New Board Appointments 7/14/2008 8:42:16 AM